Pharmaceuticals Acquisitions in Tennessee

Kobayashi Pharmaceutical Co., Ltd. (via its subsidiary Kobayashi Healthcare International Inc.) has acquired 100% of Focus Consumer Healthcare, a Chattanooga-based marketer of OTC medicines and dietary supplements. The acquisition gives Kobayashi a foothold in the U.S. supplement market and expands its North American OTC presence by combining Focus's niche brands (GARLIQUE, PAMPRIN, HERPECIN L) with Kobayashi's materials, prescription expertise, and marketing capabilities.

Lantheus Holdings, Inc. acquired Knoxville-based Cerveau Technologies, Inc., gaining MK-6240, a clinical-stage F-18 PET imaging agent that targets Tau tangles in Alzheimer's disease. The stock purchase includes upfront and potential milestone payments plus royalty obligations and will expand Lantheus' radiopharmaceutical diagnostic imaging pipeline and research collaborations.